Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 61, No. 1, 2009   

Free Abstract     Article (Fulltext)     Article (PDF 288 KB)     
Free Access

Review

Rett Syndrome: From the Gene to the Disease
Tanja Matijevic, Jelena Knezevic, Marko Slavica, Jasminka Pavelic

Rudjer Boskovic Institute, Division of Molecular Medicine, Zagreb, Croatia

Address of Corresponding Author

Eur Neurol 2009;61:3-10 (DOI: 10.1159/000165342)


 goto top of page Key Words

  • MECP2 gene
  • Neurodevelopmental disorder
  • Rett syndrome

 goto top of page Abstract

Rett syndrome (RTT, MIM No. 312750) is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation. It is transmitted as an X-linked dominant trait, therefore almost exclusively affecting females. About 80% of RTT cases are sporadic caused by mutations in the MECP2 gene located on Xq28. The gene codes for two isoforms of the methyl-CpG-binding protein (MeCP2, MeCP2B) which are involved in transcriptional silencing through DNA methylation. The gene has 4 exons. The fourth one is the largest. Almost all mutations in MECP2 occur de novo. Although mutations are dispersed throughout the gene, about 67% of all MECP2 mutations, caused by C>T transitions at 8 CpG dinucleotides, are located in the third and fourth exon. The most common mutation is R168X. So far, there is no clear evidence on genotype-phenotype correlations. There are also reports claiming that the same mutation can provoke different phenotypes. It was shown that MeCP2 can silence certain genes. One of them, brain-derived neurotrophic factor, is essential for neural plasticity, learning and memory. This discovery revealed the role of MeCP2 in the control of neuronal activity-dependent gene regulation and suggested that the pathology of RTT may result from deregulation of this process.

Copyright © 2008 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. Dr. Jasminka Pavelic
Rudjer Boskovic Institute, Division of Molecular Medicine, Laboratory of Molecular Oncology, Bijenicka 54
HR-10002 Zagreb (Croatia)
Tel. +385 1 4560 926, Fax +385 1 456 1010, E-Mail jpavelic@irb.hr


 goto top of page Article Information

Received: February 1, 2008
Accepted: April 14, 2008
Published online: October 24, 2008
Number of Print Pages : 8
Number of Figures : 3, Number of Tables : 1, Number of References : 62

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18948693)
Download Citation



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Neurology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel